Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Aug 2016

Alberobello Anna Teresa, Wang Yisong, Beerkens Frans Joseph, Conforti Fabio, McCutcheon Justine N, Rao Guanhua, Raffeld Mark, Liu Jing, Rahhal Raneen, Zhang Yu-Wen, Giaccone Giuseppe

Abstract excerpt

INTRODUCTION: Thymic epithelial tumors (TETs) are rare tumors originating from the epithelium of the thymus with limited therapeutic options beyond surgery. The pathogenesis of TETs is poorly understood, and the scarcity of model systems for these rare tumors makes the study of their biology very challenging. METHODS: A new cell line (MP57) was established from a thymic carcinoma specimen and characterized using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms, Glandular and Epithelial

Share to Phosphatidylinositol 3-Kinases

Share to Phosphoinositide-3 Kinase Inhibitors

Share to Thymus Neoplasms

Share to Xenograft Model Antitumor Assays

Source

Open in PubMed Open full text

Identifiers

PMID: 27117832
DOI: 10.1016/j.jtho.2016.04.013
PMCID: PMC5319212

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors.PMID 27117832Read ↗

Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers.Semantic proximity Read ↗

Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.Semantic proximity Read ↗

The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive ReviewSemantic proximity Read ↗

A Tuft Cell–Like Signature Is Highly Prevalent in Thymic Squamous Cell Carcinoma and Delineates New Molecular Subsets Among the Major Lung Cancer HistotypesSemantic proximity Read ↗

Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.Semantic proximity Read ↗

Deciphering the biology of thymic epithelial tumorsSemantic proximity Read ↗

Thymic epithelial tumors: From biology to treatment.Semantic proximity Read ↗

The Integrated Genomic Landscape of Thymic Epithelial Tumors.Semantic proximity Read ↗

Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.Semantic proximity Read ↗

Medical treatment involving investigational drugs and genetic profile of thymic carcinoma.Semantic proximity Read ↗

Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in KIT, ERBB2, KRAS, and TP53 in 30% of Thymic CarcinomasSemantic proximity Read ↗

Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signaturesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.